Enovis Corp (LTS:0I1B)
$ 48.35 -0.10705 (-0.22%) Market Cap: 2.73 Bil Enterprise Value: 4.11 Bil PE Ratio: 0 PB Ratio: 0.82 GF Score: 68/100

Enovis Corp at Canaccord Genuity Musculoskeletal Conference Transcript

Feb 12, 2024 / 10:30PM GMT
Release Date Price: $60.93 (+1.48%)
Caitlin Cronin
Canaccord Genuity Corp., Research Division - Associate

Good afternoon, everyone, and thank you for joining us at this year's Canaccord Genuity Musculoskeletal Conference. My name is Caitlin Cronin, and I'm one of the medical device analysts here at Canaccord Genuity.

I'm pleased to be joined this afternoon by Enovis, a medical device company focused on products spanning the orthopedic care continuum, including injury prevention, repair and recovery, with the goal of improving patient outcomes and transforming procedural and clinical workflows.

With me today is Ben Berry, CFO; Brady Shirley, COO; and Louie Vogt, Recon Group President.

Before we begin, I want to remind everyone of any relevant disclosures which can be found on our conference and our firm website. And with that, I'll turn it over to management for a brief presentation.

Phillip Benjamin Berry
Enovis Corporation - Senior VP & CFO

Thanks, Caitlin. Good afternoon, everyone. I'm Ben Berry, the CFO of Enovis. I'm going to take you through a really brief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot